Literature DB >> 17586090

Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.

Kevin Damman1, Gerjan Navis, Tom D J Smilde, Adriaan A Voors, Wim van der Bij, Dirk J van Veldhuisen, Hans L Hillege.   

Abstract

BACKGROUND: Renal failure in heart failure is related to decreased cardiac output. However, little is known about its association with venous congestion. AIMS: To investigate the relationship between venous congestion and glomerular filtration rate (GFR) in patients with cardiac dysfunction. METHODS AND
RESULTS: Right atrial pressure (RAP) and cardiac index (CI) were determined by right heart catheterisation in 51 patients with cardiac dysfunction, secondary to pulmonary hypertension. GFR and renal blood flow (RBF) were measured as (125)I-Iothalamate and (131)I-Hippuran clearances, respectively. Mean age was 40+/-11 years and 69% of patients were female. GFR was 73+/-19 ml/min/1.73 m2 with a CI of 2.1+/-0.7 l/min/m2. In multivariate analysis, RBF (r=0.664, p<0.001) and RAP (r=- 0.367, p=0.020) were independently associated with GFR. In patients in the lower ranges of RBF, venous congestion was an important determinant of renal function.
CONCLUSION: RBF is the main factor determining GFR in patients with cardiac dysfunction. Venous congestion, characterised by an increased RAP, adjusted for RBF is also related to GFR. Treatment to preserve GFR should not only focus on improvement of renal perfusion, but also on decreasing venous congestion.

Entities:  

Mesh:

Year:  2007        PMID: 17586090     DOI: 10.1016/j.ejheart.2007.05.010

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  123 in total

Review 1.  Cardiohepatic syndrome.

Authors:  Gerhard Poelzl; Johann Auer
Journal:  Curr Heart Fail Rep       Date:  2015-02

2.  Management of the cardiorenal syndrome in acute heart failure.

Authors:  Valentina Lazzarini; G Michael Felker
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

3.  Predictability of tricuspid annular plane systolic excursion for the effectiveness of tolvaptan in patients with heart failure.

Authors:  Toru Niwa; Katsuhisa Waseda; Tomofumi Mizuno; Yusuke Nakano; Kentaro Mukai; Hirokazu Wakabayashi; Atsushi Watanabe; Hirohiko Ando; Hiroaki Takashima; Tetsuya Amano
Journal:  J Echocardiogr       Date:  2017-02-13

Review 4.  Managing acute renal failure in patients with acute decompensated heart failure: the cardiorenal syndrome.

Authors:  Ravi V Shah; Michael M Givertz
Journal:  Curr Heart Fail Rep       Date:  2009-09

Review 5.  Right Heart Failure and Cardiorenal Syndrome.

Authors:  Thida Tabucanon; Wai Hong Wilson Tang
Journal:  Cardiol Clin       Date:  2020-03-02       Impact factor: 2.213

6.  Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.

Authors:  Horng H Chen; Omar F AbouEzzeddine; Kevin J Anstrom; Michael M Givertz; Bradley A Bart; G Michael Felker; Adrian F Hernandez; Kerry L Lee; Eugene Braunwald; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2013-09-01       Impact factor: 8.790

7.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.

Authors:  Wilfried Mullens; Zuheir Abrahams; Gary S Francis; George Sokos; David O Taylor; Randall C Starling; James B Young; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2009-02-17       Impact factor: 24.094

8.  Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats.

Authors:  John Baynes; David B Murray
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

9.  The cardiorenal syndrome: making the connection.

Authors:  Gautham Viswanathan; Scott Gilbert
Journal:  Int J Nephrol       Date:  2010-10-04

10.  Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.

Authors:  Alain Cohen-Solal; Dipak Kotecha; Dirk J van Veldhuisen; Daphne Babalis; Michael Böhm; Andrew J Coats; Michael Roughton; Philip Poole-Wilson; Luigi Tavazzi; Marcus Flather
Journal:  Eur J Heart Fail       Date:  2009-08-01       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.